The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2014

Filed:

Jul. 02, 2007
Applicants:

Kenneth Egnard Lind, Belmont, MA (US);

Kathy Cao, Sunnyvale, CA (US);

Edward Yin-shiang Lin, Chestnut Hill, MA (US);

Thinh BA Nguyen, Santa Clara, CA (US);

Bradley T. Tangonan, San Francisco, CA (US);

Daniel A. Erlanson, San Francisco, CA (US);

Kevin Guckian, Marlborough, MA (US);

Robert Lowell Simmons, San Francisco, CA (US);

Wen-cherng Lee, Lexington, MA (US);

Lihong Sun, Lexington, MA (US);

Stig Hansen, Kensington, CA (US);

Nuzhat Pathan, San Diego, CA (US);

Lei Zhang, Cheshire, CT (US);

Inventors:

Kenneth Egnard Lind, Belmont, MA (US);

Kathy Cao, Sunnyvale, CA (US);

Edward Yin-shiang Lin, Chestnut Hill, MA (US);

Thinh Ba Nguyen, Santa Clara, CA (US);

Bradley T. Tangonan, San Francisco, CA (US);

Daniel A. Erlanson, San Francisco, CA (US);

Kevin Guckian, Marlborough, MA (US);

Robert Lowell Simmons, San Francisco, CA (US);

Wen-cherng Lee, Lexington, MA (US);

Lihong Sun, Lexington, MA (US);

Stig Hansen, Kensington, CA (US);

Nuzhat Pathan, San Diego, CA (US);

Lei Zhang, Cheshire, CT (US);

Assignee:

Sunesis Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/4985 (2006.01); A61K 31/444 (2006.01); A61K 31/4439 (2006.01); A61K 31/4436 (2006.01); A61K 31/443 (2006.01); A61K 31/4412 (2006.01); C07D 487/04 (2006.01); C07D 471/04 (2006.01); C07D 417/14 (2006.01); C07D 417/12 (2006.01); C07D 413/14 (2006.01); C07D 413/12 (2006.01); C07D 409/14 (2006.01); C07D 409/12 (2006.01); C07D 405/14 (2006.01); C07D 405/12 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 211/86 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4412 (2013.01); A61K 31/5377 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/4985 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/4436 (2013.01); A61K 31/443 (2013.01); C07D 487/04 (2013.01); C07D 471/04 (2013.01); C07D 417/14 (2013.01); C07D 417/12 (2013.01); C07D 413/14 (2013.01); C07D 413/12 (2013.01); C07D 409/14 (2013.01); C07D 409/12 (2013.01); C07D 405/14 (2013.01); C07D 405/12 (2013.01); C07D 401/14 (2013.01); C07D 401/12 (2013.01); C07D 211/86 (2013.01);
Abstract

The present invention provides pyridinonyl PDK1 inhibitors and methods of treating cancer using the same.


Find Patent Forward Citations

Loading…